ACTA’s Innovative Outcome Data reference group is hosting a virtual workshop across two half-days for key stakeholders to address barriers to uptake of registry randomised trials.

This event will provide a forum for trialists, registry scientists, statisticians, healthcare managers, healthcare policymakers and consumers to exchange experiences, best practices and ideas related to current and emerging issues associated with registry randomised trials.